Cabinet Clears Rs 15 Billion Biomedical Research Career Phase III

03 Oct 2025 CW Team

Launched in 2008–09 through the DBT/Wellcome Trust India Alliance, the BRCP has been instrumental in supporting world-class biomedical research in India. Phase II was rolled out in 2018–19 with an expanded portfolio, and Phase III will build on this foundation to nurture scientific talent, foster translational innovation, and reduce regional disparities in research capacity.

Phase III will introduce:

Early Career and Intermediate Fellowships in basic, clinical and public health, tailored for formative stages of scientists.
Collaborative Grants, including Career Development and Catalytic Collaborative Grants for early and mid-senior researchers with strong track records.
Research Management Programme to strengthen core research efforts, mentorship, networking, public engagement and international collaborations.

The programme aims to train over 2,000 students and postdoctoral fellows, deliver high-impact publications, enable patentable discoveries, and provide stronger support for women researchers (10–15 per cent increase). It also targets 25–30 per cent of collaborative programmes advancing to Technology Readiness Level (TRL) 4 or above, while expanding engagement in Tier-2 and Tier-3 regions.

Phases I and II established India as an emerging hub for biomedical sciences of global standing. Phase III, aligned with Viksit Bharat goals, will strengthen India’s biomedical research ecosystem, enhance innovation, and cement its place in the global knowledge economy.

The Union Cabinet chaired by Prime Minister Narendra Modi has approved the continuation of the Biomedical Research Career Programme (BRCP) Phase III, a joint initiative of the Department of Biotechnology (DBT), Government of India, and the Wellcome Trust (WT), United Kingdom. The programme will run from 2025–26 to 2030–31, with an additional six years (2031–32 to 2037–38) to service fellowships and grants, at a total cost of Rs 15 billion, of which DBT will contribute Rs 10 billion and WT Rs 5 billion.Launched in 2008–09 through the DBT/Wellcome Trust India Alliance, the BRCP has been instrumental in supporting world-class biomedical research in India. Phase II was rolled out in 2018–19 with an expanded portfolio, and Phase III will build on this foundation to nurture scientific talent, foster translational innovation, and reduce regional disparities in research capacity.Phase III will introduce:Early Career and Intermediate Fellowships in basic, clinical and public health, tailored for formative stages of scientists.Collaborative Grants, including Career Development and Catalytic Collaborative Grants for early and mid-senior researchers with strong track records.Research Management Programme to strengthen core research efforts, mentorship, networking, public engagement and international collaborations.The programme aims to train over 2,000 students and postdoctoral fellows, deliver high-impact publications, enable patentable discoveries, and provide stronger support for women researchers (10–15 per cent increase). It also targets 25–30 per cent of collaborative programmes advancing to Technology Readiness Level (TRL) 4 or above, while expanding engagement in Tier-2 and Tier-3 regions.Phases I and II established India as an emerging hub for biomedical sciences of global standing. Phase III, aligned with Viksit Bharat goals, will strengthen India’s biomedical research ecosystem, enhance innovation, and cement its place in the global knowledge economy.

Real Estate

07 Jul 2026

Pecan Realty Completes Rs 1.5 Billion Transactions

Pecan Realty has recently completed four institutional transactions worth over Rs 1.5 billion over the past two years, strengthening its position as an execution-led real estate platform. The deals include resolution-led acquisitions, structured finance transactions and capital partnerships across its development portfolio.The transactions covered acquisitions through the National Company Law Tribunal process and helped provide repayment or exits to both private and public sector lenders. The company said the deals demonstrate its ability to resolve complex project situations, work with instit..

Real Estate

07 Jul 2026

SNN Estates Expands North Bengaluru Housing Project

SNN Estates has announced an expansion of its SNN Estates Felicity residential project in North Bengaluru following strong buyer demand, with 75 per cent of the first-phase inventory sold within three days of launch.The developer will add 76 apartments in the new phase, taking the project's estimated revenue potential to around Rs 1,000 crore upon completion of Phase 2.Spread across 6.5 acres in Rachenahalli, near Manyata Tech Park, the project comprises 604 apartments in 1.5, 2, 2.5, 3 and 4 BHK configurations. The development includes a 50,000-sq-ft clubhouse with amenities such as sports co..

Infrastructure Urban

07 Jul 2026

SCG Drives ASEAN Industrial Transformation Strategy

SCG is strengthening its focus on ASEAN as a key growth region by advancing industrial transformation, enhancing competitiveness and building resilient regional value chains. Thammasak Sethaudom, President and Chief Executive Officer, SCG, highlighted the need for industries to continuously develop capabilities, strengthen resilience and deepen regional cooperation to achieve sustainable long-term growth.SCG views ASEAN as an important growth engine alongside China, supported by favourable demographics, trade connectivity and investment flows. With ASEAN’s GDP projected to grow by around 4.7..